Biotechnology

Cas-cading events in the IP battle over CRISPR technologies

Cas-cading events in the IP battle over CRISPR technologies On 15 February the USPTO announced its long-awaited decision regarding the CRISPR patent interference proceedings between the University of California Berkley (UCB) and the Broad Institute of MIT. The decision closes the door on an important chapter of the increasingly bitter...

Read more

A new ‘parth-way’ around Article 53(a) EPC for inventions requiring the use of human embryonic stem cell lines

A recent change in EPO practice allows for European patent applications requiring the use of human embryonic stem cell (hESC) lines to avoid the morality exclusion of Article 53(a) EPC, provided the effective date of the application is on or after 5 June 2003. By way of background, according to...

Read more